| Literature DB >> 22873568 |
Vassily A Lyubetsky1, Oleg A Zverkov, Sergey A Pirogov, Lev I Rubanov, Alexandr V Seliverstov.
Abstract
BACKGROUND: In previous work, we introduced a concept, a mathematical model and its computer realization that describe the interaction between bacterial and phage type RNA polymerases, protein factors, DNA and RNA secondary structures during transcription, including transcription initiation and termination. The model accurately reproduces changes of gene transcription level observed in polymerase sigma-subunit knockout and heat shock experiments in plant plastids. The corresponding computer program and a user guide are available at http://lab6.iitp.ru/en/rivals. Here we apply the model to the analysis of transcription and (partially) translation processes in the mitochondria of frog, rat and human. Notably, mitochondria possess only phage-type polymerases. We consider the entire mitochondrial genome so that our model allows RNA polymerases to complete more than one circle on the DNA strand.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22873568 PMCID: PMC3583402 DOI: 10.1186/1745-6150-7-26
Source DB: PubMed Journal: Biol Direct ISSN: 1745-6150 Impact factor: 4.540
Figure 1Mitochondrial genome of The entire circular DNA is presented sequentially as four rows. Genes in the heavy strand (H-strand) are shown by green arrows, and genes in the light strand (L-strand) – by blue arrows. HSP1, HSP2 are two promoters in the H-strand. LSP1, LSP2A, LSP2B are three promoters in the L-strand. mTERF symbolizes a binding site of the protein factor mTERF acting as transcription terminator.
Figure 2Mitochondrial genome of All symbols are the same as in Figure 1.
Figure 3Mitochondrial genome of All symbols are the same as in Figure 1.
Transcription initiation sites in mitochondria
| [Genbank:NC_012920.1] | HSP1 | 561 | |
| HSP2 | 646 | ||
| LSP | (407) | ||
| [Genbank:NC_001665.2] | HSP1 | 16298 | |
| HSP2 | 66 | ||
| LSP | (16193) | ||
| [Genbank:NC_001573.1] | HSP1 | 2102 | |
| | | HSP2 | 2049 |
| | | LSP1 | (2103) |
| | | LSP2A | (2042) |
| LSP2B | (2033) |
Positions in the complementary L-strand are shown in parentheses.
Transcription initiation intensities relative to the LSP1 promoter in frog mitochondria
| HSP1 | 13.6 |
| HSP2 | 60.0 |
| LSP1 | 100.0 |
| LSP2A | 16.6 |
| LSP2B | 38.2 |
Data are from [17].
The mTERF terminator passage probabilities on the heavy and light strands
| 500 | 0.0164 | 0.0056 | 11.243 | 3.193 | 0.043 | 2.098 |
| 200 | 0.2165 | 0.0015 | 10.844 | 3.240 | 0.309 | 2.235 |
The minimum of L1n for three frog specimens, and minimum of L1n(total) are shown. For comparison, the same minima are given for the RNA polymerase elongation rate of 200 nt/s.
Agreement between the model and experiment for three frog specimens
| Egg | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | ||
| +5 h | 1.0 | 1.1 | −12 | 0.9 | 0.8 | +14 | 0.9 | 0.9 | +1 | 0.9 | 2.1 | −59 | 2.4 | 2.4 | −1 | 0.8 | 0.7 | +19 | ||
| +10 h | 1.2 | 1.3 | −5 | 1.1 | 1.1 | +1 | 1.1 | 0.7 | +56 | 1.0 | 2.3 | −57 | 4.1 | 4.0 | +2 | 0.9 | 0.6 | +50 | ||
| +14 h | 1.7 | 2.3 | −26 | 1.6 | 1.6 | −3 | 1.5 | 1.3 | +18 | 1.4 | 3.0 | −53 | 4.4 | 4.4 | 0 | 1.2 | 1.2 | +3 | ||
| +16 h | 2.0 | 2.9 | −31 | 1.7 | 1.4 | +24 | 1.7 | 1.3 | +31 | 1.5 | 4.3 | −65 | 5.6 | 5.8 | −4 | 1.3 | 1.3 | +2 | ||
| +18 h | 2.1 | 3.2 | −34 | 1.9 | 1.7 | +14 | 1.9 | 1.9 | +1 | 1.8 | 4.5 | −60 | 4.4 | 4.2 | +4 | 1.6 | 1.3 | +25 | ||
| +20 h | 1.8 | 3.0 | −41 | 1.6 | 1.4 | +13 | 1.6 | 1.8 | −12 | 1.5 | 4.6 | −68 | 4.2 | 4.2 | 0 | 1.3 | 1.2 | +8 | ||
| +23 h | 9.4 | 9.7 | −4 | 7.6 | 5.1 | +49 | 7.4 | 6.5 | +14 | 6.4 | 16.1 | −60 | 12.9 | 12.2 | +5 | 5.3 | 5.2 | +2 | ||
| +48 h | 29.3 | 26.6 | +10 | 26.2 | 13.4 | +96 | 26.0 | 26.1 | 0 | 23.8 | 60.3 | −61 | 18.6 | 18.6 | 0 | 20.2 | 23.4 | −14 | ||
| +96 h | 48.1 | 48.7 | −1 | 45.3 | 20.9 | +117 | 45.4 | 48.3 | −6 | 43.3 | 104.2 | −58 | 16.7 | 17.4 | −4 | 38.8 | 39.3 | −1 | ||
| | | |||||||||||||||||||
| Egg | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | 1.0 | 1.0 | | ||
| +6 h | 1.2 | 1.3 | −8 | 1.2 | 1.0 | +22 | 1.2 | 1.3 | −5 | 1.2 | 1.4 | −12 | 0.7 | 0.7 | +6 | 1.2 | 1.2 | +3 | ||
| +9 h | 1.3 | 1.5 | −14 | 1.3 | 1.3 | −1 | 1.3 | 1.2 | +8 | 1.3 | 1.6 | −19 | 1.1 | 1.1 | +1 | 1.3 | 1.3 | −1 | ||
| +20 h | 3.8 | 4.6 | −17 | 3.7 | 3.7 | +1 | 3.7 | 3.7 | +1 | 3.7 | 3.7 | 0 | 2.8 | 2.8 | −2 | 3.6 | 4.0 | −11 | ||
| +30 h | 7.2 | 7.2 | 0 | 7.1 | 6.8 | +4 | 7.1 | 8.1 | −13 | 7.0 | 6.2 | +14 | 3.7 | 3.7 | 0 | 6.8 | 8.1 | −17 | ||
| +48 h | 20.5 | 19.5 | +5 | 19.7 | 19.7 | 0 | 19.6 | 28.7 | −32 | 19.1 | 17.7 | +8 | 8.6 | 8.4 | +2 | 17.3 | 23.1 | −25 | ||
| +7 days | 6.5 | 6.1 | +7 | 6.6 | 8.0 | −18 | 6.6 | 8.5 | −22 | 6.7 | 4.9 | +36 | 2.4 | 2.3 | +3 | 6.6 | 6.6 | +1 | ||
| | | | | | | | | | | | | |||||||||
| | | | | | | | | | | | | | | |||||||
| Egg | 1.0 | 1.0 | | 1.0 | 1.0 | | | | | | | | | | | | | | ||
| +5 h | 2.2 | 2.2 | +0.9 | 2.2 | 2.2 | 0.0 | | | | | | | | | | | | | ||
| +14 h | 5.0 | 5.0 | 0.0 | 4.5 | 4.5 | −0.2 | | | | | | | | | | | | | ||
| +20 h | 5.9 | 6.0 | −1.3 | 4.0 | 4.0 | +0.5 | | | | | | | | | | | | | ||
| +28 h | 92.2 | 92.0 | +0.2 | 25.1 | 25.0 | +0.4 | | | | | | | | | | | | | ||
| +48 h | 44.1 | 44.0 | +0.2 | 15.0 | 15.0 | +0.3 | ||||||||||||||
In columns: “time” gives absolute times of embryonic development; “mTERF“ and “ LSP1” are intensities of the mTERF factor binding with the termination site and cooperative binding with the promoter, respectively, under the polymerase rate of 500 nt/s; further columns are modeled (mod) and experimental (exp) gene transcription levels and their relative deviations (dev) obtained with equation (9). Variables are in bold.
Agreement between the model and experiment for healthy human and human with MELAS syndrome
| 23.955 | 1.945 | 1.00 | 1.00 | 1.00 | 0.96 | 0.96 | 0.96 | 0.96 | ||||
| Experimental estimates | Transcription level: | 1.40 | 1.04 | 1.72 | 0.91 | 1.04 | 1.86 | 2.31 | ||||
| | Error (if statistically independent): | ±0.23 (1.8) | ±0.52 (0.1) | ±0.61 (1.2) | ±0.43 (0.1) | ±0.12 (0.7) | ±0.56 (1.6) | ±0.56 (2.4) | ||||
| | Error (if statistically dependent): | ±0.40 (1.0) | ±0.82 (0.1) | ±0.95 (0.8) | ±0.71 (0.1) | ±0.20 (0.4) | ±0.99 (0.9) | ±1.01 (1.3) | ||||
| Deviation from the experiment,%: | −29 | −4 | −42 | +5 | −4 | −48 | −58 | |||||
| | | | | | | |||||||
| 24.333 | 3.84 | 1.20 | 1.20 | 1.20 | 1.16 | 1.22 | 1.17 | |||||
Inferences are obtained under the polymerase rate of 500 nt/s and the values of p, q estimated for the frog.
Left panel: the solutions for healthy human (upper part) and human with MELAS syndrome (lower part). Variables and predicted values are in bold. Intensities decrease 7.75 times for HSP1 and 1.21 times for mTERF; RNA/RNA− =1.18, R = 24. The L1n minima differ by 2.4% if general conditions are only imposed.
Right panel (upper part): Transcription levels of seven genes (relative to ND1 gene) in the model and experiment for healthy human. Experimental errors were estimated for both cases of statistically independent measurements and counter assumption. In the latter case, the model results are within experimental error, except for the CYTB gene. Differences between model and experimental estimates are shown in parentheses in the error radius units.
Right panel (lower part): For selected genes, decrease of their transcription levels in the model in MELAS case comparing to healthy human. The transcription level of tRNA-Phe drops 3.8-fold, of 12 S and 16 S – 1.2-fold. The Leu and Lys transcription levels decrease 1.2-fold, which agree with experimental observations.
Experimental data on mitochondrial transcripts in rat
| 16 S | | 44.48 ± 6.34 | | 87.50 ± 27.52 |
| COX1 | 100 ± 16 | 84.41 ± 27.49 | 86 ± 13 | 235.12 ± 48.68 |
| ATP6/8 | 100 ± 19 | 78.14 ± 21.05 | 59 ± 9 | 277.52 ± 31.58 |
| COX3 | 100 ± 19 | 78.14 ± 21.05 | 59 ± 9 | 277.52 ± 31.58 |
| ND4/4 L | 100 ± 16 | 84.41 ± 27.49 | 86 ± 13 | 235.12 ± 48.68 |
| ND5 | 100 ± 25 | 46.00 ± 10.41 | 52 ± 11 | 60.52 ± 5.92 |
| CYTB | 100 ± 27 | 63.70 ± 7.82 | 57 ± 7 | 204.30 ± 28.64 |
Data are from [14]; the ± signs stand for standard deviations. For each gene, mRNA/rRNA ratios were normalized with euthyroid rat values taken for 100%.
Agreement between the model and experiment for euthyroid and hypothyroid rats
| 30.605 | 1.736 | 0.666 | 0.641 | 0.646 | 0.622 | 0.614 | 0.613 | |||
| 30.637 | | 0.61 | 0.33 | 0.33 | 0.61 | 0.78 | 0.35 | |||
| Error (if statistically independent): | ±0.35 (0.2) | ±0.17 (1.9) | ±0.17 (1.9) | ±0.34 (0.0) | ±0.42 (0.6) | ±0.17 (1.5) | ||||
| Error (if statistically dependent): | ±0.79 (0.1) | ±0.39 (0.8) | ±0.39 (0.8) | ±0.79 (0.0) | ±0.97 (0.2) | ±0.39 (0.7) | ||||
| Deviation from the experiment,%: | +9 | +94 | +96 | +2 | −21 | +75 | ||||
Inferences are obtained under the polymerase elongation rate of 500 nt/s and the values of p, q estimated for the frog.
Upper left part: the solutions for the euthyroid (upper row) and hypothyroid (lower row) rats. Variables and predicted values are in bold. Note that HSP = HSP1 + HSP2.
The right part: experimental data and model predictions. Experimental errors were estimated for both cases of statistically independent measurements and counter assumption. In the latter case, the model results are within experimental error. Differences between model and experimental estimates are shown in parentheses in the error radius units.
Figure 4LSP1 promoter binding intensities plotted against time for three frog embryos. The LSP1 promoter binding intensities mostly increase in agreement with [19].
Figure 5Transcription numbers predicted during 9 hours of modeled physical time.A, B, C – frog embryos 1, 2, 3; D – healthy human; E – human with the MELAS phenotype; F – euthyroid rat; G – hypothyroid rat. Genes on the heavy strand are in green, on the light strand – in blue. Shaded are mean values, not shaded – standard errors.